Literature DB >> 352153

Cervical bacterial flora in patients with gynecologic malignancies.

J G Blythe.   

Abstract

Radiation and gynecologic oncologists agree that pelvic irradiation in the presence of pelvic inflammatory disease, parametritis, or pyometra can be catastrophic. A temperature elevation in a patient having intrauterine radiation is very perplexing. This study was designed to investigate one of the three reported etiologies for this condition. Some investigators have suggested an exacerbation of a quiescent infection as a possible etiology because of the necrotic condition of many cancerous cervices. Aerobic, anaerobic, and fungus cultures were performed on 32 patients prior to intrauterine administration of cesium. The organisms cultured were similar to those identified as the normal cervical flora. The frequency of the organisms seemed independent of the amount of irradiation. The number of organisms cultured did not vary with the use or nonuse of cleansing vaginal suppositories. This study indicated no increase in bacterial growth in these cancerous necrotic cervices; also it did not indicate the growth of any unusual pathologic bacteria.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 352153     DOI: 10.1016/0002-9378(78)90420-9

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  3 in total

1.  Endometrial bacteriology in patients with endometrial cancer before and after primary intracavitary irradiation using IR-192 and an afterloading technique.

Authors:  G J Gerstner; H Kucera; K Weghaupt; M Rotter
Journal:  Arch Gynecol       Date:  1982

2.  Pyometra.

Authors:  D Muram; P Drouin; F E Thompson; H Oxorn
Journal:  Can Med Assoc J       Date:  1981-09-15       Impact factor: 8.262

Review 3.  Systematic Review: The Impact of Cancer Treatment on the Gut and Vaginal Microbiome in Women With a Gynecological Malignancy.

Authors:  Ann Muls; Jervoise Andreyev; Susan Lalondrelle; Alexandra Taylor; Christine Norton; Ailsa Hart
Journal:  Int J Gynecol Cancer       Date:  2017-09       Impact factor: 3.437

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.